
Remedium Lifecare Ltd is Rated Strong Sell
2026-05-13 10:10:52Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 May 2026, providing investors with the latest insights into its performance and prospects.
Read MoreDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding The Order Passed By HonBle National Company Law Appellate Tribunal (NCLAT) Principal Bench New Delhi
30-Jun-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (LODR) 2015
Closure of Trading Window
27-Jun-2026 | Source : BSEIntimation for closure of Trading Window
Intimation Of Change In Insolvency Professional - Appointment Of Resolution Professional (RP) In Place Of Interim Resolution Professional (IRP)
12-May-2026 | Source : BSEAppointment of Resolution Professional in place of Interim Resolution Professional
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Remedium Lifecare Ltd has announced 1:5 stock split, ex-date: 23 Feb 24
Remedium Lifecare Ltd has announced 3:1 bonus issue, ex-date: 05 Jul 24
Remedium Lifecare Ltd has announced 61:50 rights issue, ex-date: 15 Apr 25